✦ LIBER ✦

Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study

✍ Scribed by E. S. Hong; A. R. Khang; J. W. Yoon; S. M. Kang; S. H. Choi; K. S. Park; H. C. Jang; H. Shin; G. A. Walford; S. Lim

Book ID: 115185073
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 586 KB
Volume: 14
Category: Article
ISSN: 1462-8902
DOI: 10.1111/j.1463-1326.2012.01600.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety comparison between l

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity

✍ Chun-jun Li, Jing Li, Qiu-mei Zhang, Lin Lv, Rui Chen, Chun-feng Lv, Pei Yu, De- 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 240 KB

Efficacy and Safety of Linagliptin as Ad

Efficacy and Safety of Linagliptin as Add-on Therapy to Basal Insulin in Patients With Type 2 Diabetes

✍ Yki-Jarvinen, Hannele; Duran-Garcia, Santiago; Pinnetti, Sabine; Bhattacharya, S 📂 Article 📅 2012 🏛 Canadian Diabetes Association 🌐 English ⚖ 126 KB

Sitagliptin add-on to low dosage sulphon

Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes

✍ S-I. Harashima; M. Ogura; D. Tanaka; T. Fukushima; Y. Wang; T. Koizumi; M. Aono; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 251 KB

Introducing a simplified approach to ins

Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs

✍ M. R. Lankisch; K. C. Ferlinz; J. L. Leahy; W. A. Scherbaum; Orals Plus Apidra; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

Evaluation of stepwise insulin treatment

Evaluation of stepwise insulin treatment as an add-on to current oral antidiabetic drugs therapy in Japanese patients with type 2 diabetes: STEADY study

✍ Tomoko Nakagami, Masashi Honda, Naomi Shibata, Osamu Tomonaga… 📂 Article 📅 2013 🏛 Springer Japan 🌐 English ⚖ 399 KB

PDB54 COMPARISON OF TREATMENT COSTS BETW

PDB54 COMPARISON OF TREATMENT COSTS BETWEEN BASAL-SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE (GLA) AND BOT WITH INSULIN DETEMIR (DET) IN PATIENTS WITH TYPE 2 DIABETES (T2D): ECONOMIC EVALUATION BASED ON THE RESULTS OF THE INSULIN GLARGINE (LANTUS®) VERSUS INSULIN DETEMIR (LEVEMIR®) TREAT-TO-TARGET (L2T3) STUDY

✍ PK Schädlich; KC Koltermann; FW Dippel; EG Hagenmeyer; B Häussler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB